AVITA Medical (RCEL) Shareholder's Equity (QoQ) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -149.77% |
| Sep 30, 2025 | 48.29% |
| Jun 30, 2025 | -182.04% |
| Mar 31, 2025 | -201.60% |
| Dec 31, 2024 | -63.20% |
| Sep 30, 2024 | -48.87% |
| Jun 30, 2024 | -26.57% |
| Mar 31, 2024 | -33.61% |
| Dec 31, 2023 | -22.11% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | -11.49% |
| Mar 31, 2023 | -8.47% |
| Dec 31, 2022 | -3.69% |
| Sep 30, 2022 | -4.94% |
| Jun 30, 2022 | -5.37% |
| Mar 31, 2022 | -6.51% |
| Dec 31, 2021 | -6.16% |
| Sep 30, 2021 | -3.60% |
| Jun 30, 2021 | -2.76% |
| Mar 31, 2021 | 99.58% |
| Dec 31, 2020 | -9.00% |
| Sep 30, 2020 | -9.55% |
| Jun 30, 2020 | -10.86% |
| Mar 31, 2020 | -6.97% |
| Dec 31, 2019 | 386.23% |
| Sep 30, 2019 | -13.81% |